Additionally, in pancreatic cancer, cells harboring KRASG12D mutations secrete high levels of the anti-inflammatory mediators TGF-β and IL10, crucial chemokines for sustaining an immunosuppressive environment and cancer cell immune escape [41]. Here, IL10 is linked to pancreatic neoplasm.